As bird flu outbreaks in dairy cattle are raising concerns about potential human infections, the Biden administration announced Friday nearly $200 million in funding to help contain the spread.
Why it matters: The virus has been detected in cows in in at least nine states this spring. The CDC has said the general public health risk is low, but the government and scientists are closely watching for changes in the virus.
The French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing agreement worth as much as $1.2 billion that includes selling a combination COVID-flu shot.
Why it matters: It's a major turnaround for Maryland-based Novavax, one of America's first big bets under Operation Warp Speed that lost out in the COVID-19 vaccine race and warned last year about its ability to stay in business.
